Viewing Study NCT00126633


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-30 @ 5:21 PM
Study NCT ID: NCT00126633
Status: COMPLETED
Last Update Posted: 2012-09-17
First Post: 2005-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
Sponsor: University of California, San Francisco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module